Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garnet Anderson

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Archives of Internal Medicine|October 14, 2009
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer riskCarolyn J Crandall, Aaron K Aragaki, Rowan T Chlebowski, et al.
Archives of Internal Medicine|February 27, 2008
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, Mary Pettinger, et al.
Plos One|April 17, 2024
A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women's Health InitiativeHailey R Banack, Jean Wactawski-Wende, Heather M Ochs-Balcom, et al.
Journal of Toxicology and Environmental Health. Part A|November 4, 2008
Ambient particulate air pollution and ectopy--the environmental epidemiology of arrhythmogenesis in Women's Health Initiative Study, 1999-2004Duanping Liao, Eric A Whitsel, Yinkang Duan, et al.
The American Journal of Hospice & Palliative Care|October 29, 2025
Optimizing Palliative Cancer Surgery Trial Completion: Lessons Learned From Qualitative Content Analysis of S1316 - Comparative Effectiveness Trial for Malignant Bowel ObstructionMohammad Saad Farooq, Neda Amini, Virginia Sun, et al.
Cancer Research|October 3, 2003
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health InitiativeRandall E Harris, Rowan T Chlebowski, Rebecca D Jackson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancerKimberly A Lowe, Chirag Shah, Erin Wallace, et al.
British Journal of Cancer|December 14, 2017
Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational StudyMary C Playdon, Sally B Coburn, Steven C Moore, et al.
Cancer Causes & Control : CCC|December 25, 2012
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)Carolina Porras, Jesse Nodora, Rachael Sexton, et al.
Gynecologic Oncology|April 1, 2014
Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health InitiativeYang Zhou, Rowan Chlebowski, Michael J LaMonte, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Archives of Internal Medicine|October 14, 2009
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer riskCarolyn J Crandall, Aaron K Aragaki, Rowan T Chlebowski, et al.
Archives of Internal Medicine|February 27, 2008
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, Mary Pettinger, et al.
Plos One|April 17, 2024
A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women's Health InitiativeHailey R Banack, Jean Wactawski-Wende, Heather M Ochs-Balcom, et al.
Journal of Toxicology and Environmental Health. Part A|November 4, 2008
Ambient particulate air pollution and ectopy--the environmental epidemiology of arrhythmogenesis in Women's Health Initiative Study, 1999-2004Duanping Liao, Eric A Whitsel, Yinkang Duan, et al.
The American Journal of Hospice & Palliative Care|October 29, 2025
Optimizing Palliative Cancer Surgery Trial Completion: Lessons Learned From Qualitative Content Analysis of S1316 - Comparative Effectiveness Trial for Malignant Bowel ObstructionMohammad Saad Farooq, Neda Amini, Virginia Sun, et al.
Cancer Research|October 3, 2003
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health InitiativeRandall E Harris, Rowan T Chlebowski, Rebecca D Jackson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancerKimberly A Lowe, Chirag Shah, Erin Wallace, et al.
British Journal of Cancer|December 14, 2017
Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational StudyMary C Playdon, Sally B Coburn, Steven C Moore, et al.
Cancer Causes & Control : CCC|December 25, 2012
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)Carolina Porras, Jesse Nodora, Rachael Sexton, et al.
Gynecologic Oncology|April 1, 2014
Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health InitiativeYang Zhou, Rowan Chlebowski, Michael J LaMonte, et al.
Pageof 5